Evidence Level
Cod Liver Oil is a well-researched supplement that combines omega-3 fatty acids and vitamins A and D, offering various health benefits supported by both historical and contemporary studies. For bone health, vitamin D's role in calcium absorption and fracture prevention is highlighted by the VITAL study (Manson et al., 2019), which remains the largest randomized trial on this topic.
In cardiovascular outcomes, a meta-analysis of 10 trials involving 77,917 participants conducted by Aung et al. (2018) found that omega-3 supplementation reduced coronary heart disease events by 8%. However, it is important to note that the same study did not find a significant association between omega-3 fatty acid supplementation and major vascular events.
For respiratory health, Martineau et al. (2017) meta-analyzed 25 RCTs and reported that vitamin D supplementation decreased the risk of acute respiratory tract infections, particularly in individuals with vitamin D deficiency. This finding was supported by a 2022 randomized controlled trial involving 34,601 adults, which found that daily cod liver oil supplementation did not reduce the risk of SARS-CoV-2 infection or other acute respiratory infections compared to placebo (Brunvoll et al., 2022).
Cod liver oil also demonstrates benefits for joint inflammation. Goldberg & Katz (2007) confirmed that fish oil reduces pain and stiffness in rheumatoid arthritis through a meta-analysis of 17 randomized controlled trials. Additionally, Rajakumar (2003) highlighted cod liver oil's historical role in eliminating rickets as a public health issue.
A key distinction of cod liver oil compared to regular fish oil is its vitamin A content, which offers synergistic immune and bone benefits but also poses a risk of toxicity due to its upper intake limit. The evidence for cod liver oil is classified as Moderate because while omega-3 and vitamin D evidence are individually strong, there are fewer cod liver oil-specific RCTs compared to purified fish oil or vitamin D alone.